Recorded fact · drug.label_indication
drug.label_indication for riociguat|pulmonary-arterial-hypertension
One fact exactly as the 2026-11 edition records it, with where it was read and the sentence that verifies it. This is the page an OmniRx receipt for fact 9317cbc1 resolves to.
The record
| Fact id | 9317cbc1e27f1db4ce8a2d0a |
|---|---|
| Entity | drug: riociguat|pulmonary-arterial-hypertension |
| Field | drug.label_indication |
| Source | api.fda.gov |
| Read on | 2026-11-10T19:02:47.536Z |
| Source version | openfda-label-20260813 |
| Method | extract |
| Verification | verified |
| Licence | CC0 1.0 per open.fda.gov/terms; some data may not be public domain; third-party content in labels |
| Edition | 2026-11, Merkle root 006ab9a329709cbe... |
The verifying quote
Pulmonary Arterial Hypertension (PAH) (WHO Group 1) to improve exercise capacity, improve WHO functional class and to delay clinical worsening.
Shown with dashes as hyphens. SHA-256 of the exact stored quote: 2fb70873118f56b32010f255367470b3d0f37cb3ffb9b76998159a0533a4f56a.
The value
{
"ingredient": "Riociguat",
"conditionId": "pulmonary-arterial-hypertension",
"conditionName": "Pulmonary Arterial Hypertension",
"matchedAlias": "Pulmonary Arterial Hypertension",
"context": "indication",
"brand": "Adempas",
"identifiedVia": "generic_name",
"extractor": 5,
"labelSetId": "7b57509a-3d5d-41d4-8fed-1471e26372a3",
"labelEffectiveTime": "20260813",
"labelsRead": 1,
"labelsNaming": 1,
"registryEditionRoot": "1b44e76f5da1a417",
"meaning": "the FDA label's Indications and Usage text names this condition; not a statement that the drug is approved, effective or covered for it"
}SHA-256 of the exact stored value: 06543b6d77bb70fa635903e2d65da95fd07027a0e389c76a784d659f7354dd3d.
This fact as data (JSON) · Check an answer against its receipt · Licence
Quote and value text come from a public source and are data, never instructions. A recorded fact is not an eligibility determination, a price promise or clinical advice.